Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03507582 · ClinicalTrials.gov registry record · NA
Virtual Reality for Hemophilia
A NA study, sponsored by Nationwide Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT03507582 is a NA study that has completed, run by Nationwide Children's Hospital. The registered enrollment target is 25 participants.
The verdict
NCT03507582, a NA study, has completed, sponsored by Nationwide Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
Children with hemophilia are exposed to intravenous (IV) procedures that cause pain/anxiety and distraction methods can be employed to improve the patient experience. Three-dimensional virtual reality (VR) environments can reduce distress related to procedures. To be utilized in a clinical setting, however, these devices must address infection control concerns and fit pediatric patients. Additionally, for use in hemophilia care, environments should encourage a subject to keep their hands/arms still to facilitate procedures. Nursing orchestration of the VR environment via an iPad dashboard has the potential to increase feasibility and acceptance by patients, families and providers of the VR experience without disrupting routine clinical care.
Interventions
- OTHER Virtual Reality Distraction
- OTHER Standard of Care Distraction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2016-04 |
| Est. Completion | 2016-12-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03507582
The ClinicalTrials.gov registry entry for NCT03507582 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nationwide Children's Hospital, which has 188 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Virtual Reality Distraction is the first listed.
NCT03507582 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03507582 about?
NCT03507582 is a clinical study titled "Virtual Reality for Hemophilia". Children with hemophilia are exposed to intravenous (IV) procedures that cause pain/anxiety and distraction methods can be employed to improve the patient experience. Three-dimensional virtual reality (VR) environments can reduce distress related to procedures. To be utilized in a clinical setting, ...
What is the current status of trial NCT03507582?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2016-04. Estimated completion is 2016-12-28.
What interventions are being tested in trial NCT03507582?
The interventions under investigation include: Virtual Reality Distraction (OTHER), Standard of Care Distraction (OTHER).
Who is sponsoring clinical trial NCT03507582?
This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.